CARLSBAD, Calif. (AP) — CARLSBAD, Calif. (AP) — Ionis Pharmaceuticals Inc. (IONS) on Wednesday reported a loss of $124 million in its first quarter.
The Carlsbad, California-based company said it had a loss of 87 cents per share.
The results surpassed Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for a loss of $1 per share.
The drug discovery and development company posted revenue of $131 million in the period, also beating Street forecasts. Seven analysts surveyed by Zacks expected $130.6 million.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IONS at https://www.zacks.com/ap/IONS
Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.